tocopherols has been researched along with Idiopathic Parkinson Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, B; Luo, S | 1 |
| Luo, S | 1 |
| Luo, S; Wang, J | 1 |
| Klivényi, P; Rákóczi, K; Vécsei, L | 1 |
| Liu, X; Osawa, T; Yamada, N | 2 |
| Anderson, SW; Auinger, P; Chou, KL; Como, PG; Growdon, JC; Litvan, I; Marder, KS; McDermott, MP; Uc, EY | 1 |
| Eberly, SW; Fahn, S; Hyson, C; Lang, AE; Marras, C; Oakes, D; Schwid, SR; Shoulson, I | 1 |
| Ascherio, A; Auinger, P; Chen, H; Eberly, S; Huang, X; Mailman, R; Oakes, D; Schwarzschild, M | 1 |
| Holford, NH; Nutt, JG; Vu, TC | 2 |
| Fahn, S; Kieburtz, K; Lang, A; Langston, JW; LeWitt, P; Oakes, D; Olanow, CW; Penney, JB; Rudolph, A; Shoulson, I; Tanner, C | 1 |
| Lang, AE; Marras, C; McDermott, MP; Naglie, G; Rochon, PA; Rudolph, A; Tanner, CM | 1 |
| Ernst, ME; Weber, CA | 1 |
| Lang, AE; Marras, C; McDermott, MP; Naglie, G; Rochon, PA; Tanner, CM | 1 |
| Goetz, CG; Leurgans, S; Raman, R | 1 |
2 review(s) available for tocopherols and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
Topics: Animals; Creatine; Dopamine Agonists; Glatiramer Acetate; Humans; Indans; Kynurenic Acid; Micronutrients; Nerve Degeneration; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Peptides; Selegiline; Tocopherols; Ubiquinone | 2009 |
Antioxidants, supplements, and Parkinson's disease.
Topics: Antioxidants; Clinical Trials as Topic; Dietary Supplements; Glutathione; Humans; Parkinson Disease; Tocopherols; Ubiquinone; Vitamins | 2006 |
3 trial(s) available for tocopherols and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.
Topics: Aged; Antioxidants; Cohort Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Selegiline; Tocopherols | 2009 |
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Topics: Aged; Antioxidants; Antiparkinson Agents; Chi-Square Distribution; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Tocopherols; Treatment Outcome | 2002 |
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Placebo Effect; Selegiline; Tocopherols | 2002 |
11 other study(ies) available for tocopherols and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Joint modeling of multivariate longitudinal measurements and survival data with applications to Parkinson's disease.
Topics: Bayes Theorem; Humans; Longitudinal Studies; Markov Chains; Monte Carlo Method; Multivariate Analysis; Parkinson Disease; Tocopherols | 2016 |
A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time.
Topics: Bayes Theorem; Computer Simulation; Disease Progression; Drug Therapy, Combination; Humans; Longitudinal Studies; Markov Chains; Models, Statistical; Monte Carlo Method; Multivariate Analysis; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline; Tocopherols | 2014 |
Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.
Topics: Bayes Theorem; Clinical Trials as Topic; Computer Simulation; Humans; Longitudinal Studies; Models, Statistical; Multicenter Studies as Topic; Multivariate Analysis; Parkinson Disease; Selegiline; Survival Analysis; Tocopherols | 2014 |
Assessing the neuroprotective effect of antioxidative food factors by application of lipid-derived dopamine modification adducts.
Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Curcumin; Dioxoles; Dopamine; Food; Humans; Lignans; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Tandem Mass Spectrometry; Tocopherols; Tocotrienols; Xanthophylls | 2009 |
Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Antiparkinson Agents; Clinical Trials as Topic; Cognition Disorders; Female; Gastrointestinal Tract; Humans; Incidence; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Risk Assessment; Risk Factors; Selection Bias; Selegiline; Tocopherols; United States; Urogenital System | 2009 |
Assessing the neuroprotective effect of antioxidant food factors by application of lipid-derived dopamine modification adducts.
Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Curcumin; Dioxoles; Dopamine; Humans; Lignans; Neuroblastoma; Parkinson Disease; Tandem Mass Spectrometry; Tocopherols; Tocotrienols; Xanthophylls | 2010 |
Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.
Topics: Antioxidants; Cholesterol; Disease Progression; Endpoint Determination; Female; Humans; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Randomized Controlled Trials as Topic; Selegiline; Tocopherols | 2011 |
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Topics: Antiparkinson Agents; Cognition Disorders; Depression; Disability Evaluation; Disease Progression; Drug Substitution; Drug Therapy, Combination; Gait Disorders, Neurologic; Humans; Hypokinesia; Linear Models; Motor Activity; Nonlinear Dynamics; Parkinson Disease; Patient Dropouts; Postural Balance; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Tocopherols; Treatment Outcome; Tremor | 2012 |
Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cognition; Cognition Disorders; Depression; Disability Evaluation; Disease Progression; Humans; Kaplan-Meier Estimate; Middle Aged; Parkinson Disease; Patient Dropouts; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Selegiline; Severity of Illness Index; Time Factors; Tocopherols; Treatment Outcome | 2012 |
Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
Topics: Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Likelihood Functions; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Parkinson Disease; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Selegiline; Survival Analysis; Time; Tocopherols | 2005 |
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.
Topics: Activities of Daily Living; Aged; Canada; Cognition Disorders; Cohort Studies; Depressive Disorder; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Psychological Tests; Quality of Life; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline; Tocopherols; United States | 2008 |